Hormonal Management of Heavy Menstrual Bleeding in Adolescents (JAdoRE)
Status
Conditions
Details and patient eligibility
About
The goal of this study is to evaluate whether hormonal medications (such as contraceptive pill, patch, injectable progestins and hormonal intra-uterine device) have similar efficacy at managing heavy menstrual bleeding in adolescents with a bleeding disorder compared to those without. We also aim to assess the quality of life and hemoglobin and iron levels in this population.
Full description
Adolescents with heavy menstrual bleeding and willing to start a hormonal medication to reduce menstrual flow are included. At baseline and during the study period, questionnaires and blood tests are performed. Adolescents with a bleeding disorder are compared to those without. Follow-up is 1 year.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Adolescents and young adults aged < 26yo
- Presenting to the gynecology consultation at HUG
- Diagnosed with heavy menstrual bleeding (PBAC > 100)
- Willing to initiate a hormonal medication to manage heavy menstrual bleeding
Exclusion criteria
- Pregnancy or planning to become pregnant during the study period
- Already using hormonal medication for menstrual management and/or contraception
- Known anatomical uterine pathology
- Using anticoagulant or antiaggregant agents
Trial contacts and locations
Loading...
Central trial contact
Dehlia Moussaoui, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal